Glutathione S-Transferase pi
"Glutathione S-Transferase pi" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A glutathione transferase that catalyzes the conjugation of electrophilic substrates to GLUTATHIONE. This enzyme has been shown to provide cellular protection against redox-mediated damage by FREE RADICALS.
| Descriptor ID |
D051549
|
| MeSH Number(s) |
D08.811.913.225.500.500
|
| Concept/Terms |
Glutathione Transferase P1-1- Glutathione Transferase P1-1
- Glutathione Transferase P1 1
- Transferase P1-1, Glutathione
- GSTP1 Glutathione D-Transferase
- D-Transferase, GSTP1 Glutathione
- GSTP1 Glutathione D Transferase
- Glutathione D-Transferase, GSTP1
|
Below are MeSH descriptors whose meaning is more general than "Glutathione S-Transferase pi".
Below are MeSH descriptors whose meaning is more specific than "Glutathione S-Transferase pi".
This graph shows the total number of publications written about "Glutathione S-Transferase pi" by people in this website by year, and whether "Glutathione S-Transferase pi" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 1 | 0 | 1 |
| 2010 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2014 | 1 | 1 | 2 |
| 2017 | 0 | 1 | 1 |
| 2020 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Glutathione S-Transferase pi" by people in Profiles.
-
Charo LM, Homer MV, Natarajan L, Haunschild C, Chung K, Mao JJ, DeMichele AM, Su HI. Drug metabolising enzyme polymorphisms and chemotherapy-related ovarian failure in young breast cancer survivors. J Obstet Gynaecol. 2021 Apr; 41(3):447-452.
-
Chang C, Hu Y, Hogan SL, Mercke N, Gomez M, O'Bryant C, Bowles DW, George B, Wen X, Aleksunes LM, Joy MS. Pharmacogenomic Variants May Influence the Urinary Excretion of Novel Kidney Injury Biomarkers in Patients Receiving Cisplatin. Int J Mol Sci. 2017 Jun 22; 18(7).
-
Browne EP, Dinc SE, Punska EC, Agus S, Vitrinel A, Erdag GC, Anderton DL, Arcaro KF, Yilmaz B. Promoter methylation in epithelial-enriched and epithelial-depleted cell populations isolated from breast milk. J Hum Lact. 2014 Nov; 30(4):450-7.
-
Partin AW, Van Neste L, Klein EA, Marks LS, Gee JR, Troyer DA, Rieger-Christ K, Jones JS, Magi-Galluzzi C, Mangold LA, Trock BJ, Lance RS, Bigley JW, Van Criekinge W, Epstein JI. Clinical validation of an epigenetic assay to predict negative histopathological results in repeat prostate biopsies. J Urol. 2014 Oct; 192(4):1081-7.
-
Browne EP, Punska EC, Lenington S, Otis CN, Anderton DL, Arcaro KF. Increased promoter methylation in exfoliated breast epithelial cells in women with a previous breast biopsy. Epigenetics. 2011 Dec; 6(12):1425-35.
-
Wong CM, Anderton DL, Smith-Schneider S, Wing MA, Greven MC, Arcaro KF. Quantitative analysis of promoter methylation in exfoliated epithelial cells isolated from breast milk of healthy women. Epigenetics. 2010 Oct 01; 5(7):645-55.
-
DeMeo DL, Hersh CP, Hoffman EA, Litonjua AA, Lazarus R, Sparrow D, Benditt JO, Criner G, Make B, Martinez FJ, Scanlon PD, Sciurba FC, Utz JP, Reilly JJ, Silverman EK. Genetic determinants of emphysema distribution in the national emphysema treatment trial. Am J Respir Crit Care Med. 2007 Jul 01; 176(1):42-8.